Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/2005
09/14/2005EP1572870A2 Molecular sequence of pig endogenous retrovirus receptors and methods of use
09/14/2005EP1572866A2 Insect nuclear receptor genes and uses thereof
09/14/2005EP1572861A2 Ap1 amine oxidase variants
09/14/2005EP1572859A2 Dispersion of carbon nanotubes by nucleic acids
09/14/2005EP1572744A2 Immunoglobulin variants and uses thereof
09/14/2005EP1572741A1 Therapeutic and diagnostic agents
09/14/2005EP1572730A2 Nact as a target for lifespan expansion and weight reduction
09/14/2005EP1572712A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572363A2 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
09/14/2005EP1572235A2 Methods of therapy and diagnosis using targeting of cells that express lax
09/14/2005EP1572130A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572128A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/14/2005EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
09/14/2005EP1572080A2 Fgf variants and methods for use thereof
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1572067A2 Conjugates and compositions for cellular delivery
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP1571909A2 Optimized multi-epitope constructs and uses thereof
09/14/2005EP1109915B1 Nucleotide sequences for the tal gene
09/14/2005EP1013665B1 Polypeptide having water channel activity and dna sequence
09/14/2005CN1668765A Oligonucleotides for detecting microorganisms
09/14/2005CN1668742A Solid support having electrostatic layer and use thereof
09/14/2005CN1668635A Novel calpastatin (CAST) alleles
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1667123A Gene cluster responsible for synthesis of FR-008 polyketone antibiotics
09/14/2005CN1219066C Phycoerythrin beta and alpha subunit gene promotor, and preparing method and use thereof
09/14/2005CN1219059C Rice flavamonocell hrf2 gene, recombinant vector and method for transgenic breeding plant therefor
09/14/2005CN1218959C Paddy rice ethylene receptor protein, coded gene and use thereof
09/14/2005CN1218954C Human hematopoietic cell relative gene-1
09/13/2005US6943243 Control of gene expression in eukaryotic cells
09/13/2005US6943242 Design of artificial genes for use as controls in gene expression analysis systems
09/13/2005US6943034 Combinatorial strategies for polymer synthesis
09/13/2005US6943027 Contacting a nucleic acid with an organic polycation to produce a condensed nucleic acid, and then combining product with an amphiphilic cationic lipid; increased shelf life and high transfection activity
09/13/2005US6943020 Death domain containing receptor-4 antibodies
09/13/2005US6943014 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
09/13/2005US6942974 Methods and kits for the sequential elution of families of extension products from one or more substrates
09/13/2005US6942972 Preparation of oligonucleotide-protein conjugate; obtain oligonucleotide expose to linker, join, expose oligonucleotide-linker conjugate with preferential protein, join, recover oligonucleotide-protein conjugate
09/13/2005US6942971 Apparatus for analysis of a nucleic acid amplification reaction
09/13/2005US6942968 A layout comprising substrate with an array of geometrically shaped well, containing bioactive agent and signal transducer element, surfaces coated with reflective spectrum absorptive coatings, for detecting a target analyte in a sample
09/13/2005US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof
09/13/2005US6942964 Tracer reagents that enhance reaction-product analysis
09/13/2005CA2175476C Opioid receptor: compositions and methods
09/13/2005CA2123686C Method for exponential amplification of nucleic acid by a single unpaired primer
09/09/2005WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005WO2005083084A1 Intercalating triplex forming oligonucleotide derivatives and process for the preparation thereof
09/09/2005WO2005083073A1 Dna enzyme and method of controlling the activity thereof
09/09/2005WO2005082932A2 Compositions and methods using rna interference for control of nematodes in plants
09/09/2005WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005WO2005082923A1 Novel method of synthesizing nucleic acid without protecting nucleotide bases
09/09/2005WO2005082922A1 Oligonucleotides related to lipid membrane attachments
09/09/2005WO2005082921A1 Method for inhibiting cellular proliferation
09/09/2005WO2005082098A2 Polony fluorescent in situ sequencing beads
09/09/2005WO2005082073A2 Real-time polymerase chain reaction-based genotyping assay for chemokine receptor (cxcr2) single nucleotide polymorphism
09/09/2005WO2005082020A2 Flavivirus vaccines
09/09/2005WO2005081854A2 Egf receptor epitope peptides and uses thereof
09/09/2005WO2005081714A2 Use of interfering rna in the production of transgenic animals
09/09/2005WO2005062947A3 Methods and compositions for identifying rna-binding proteins
09/09/2005WO2005058957A3 Ztnf 12, a tumor necrosis factor
09/09/2005WO2005051994A3 Ztnf11, a tumor necrosis factor
09/09/2005WO2005049853A3 Compositions and methods for screening pro-apoptotic compounds
09/09/2005WO2005047481A3 Novel sequences encoding hapatitis c virus glycoproteins
09/09/2005WO2005046708A8 Selective inhibitors of nuclear factor-kb activation and uses thereof
09/09/2005WO2005044996A3 Chimeric receptors with 4-1bb stimulatory signaling domain
09/09/2005WO2005037850A3 Solid phase methods for polynucleotide production
09/09/2005WO2005036169A3 Fluorescent probes for ribosomes and method of use
09/09/2005WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
09/09/2005WO2005033265A3 Optimized multi-epitope constructs and uses thereof
09/09/2005WO2005024045A3 Primers for use in detecting beta-lactamases
09/09/2005WO2005014782A3 Double-stranded ribonucleic acid with increased effectiveness in an organism
09/09/2005WO2005000220A8 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
09/09/2005WO2005000198A3 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same
09/09/2005WO2004085608A3 Methods for high throughput elucidation of transcriptional profiles and genome annotation
09/09/2005CA2558666A1 Salivary mrna profiling, biomarkers, and related methods and kits of parts
09/09/2005CA2558581A1 Novel method for the synthesis of nucleic acid without protecting base moiety
09/09/2005CA2558256A1 Oligonucleotides related to lipid membrane attachments
09/09/2005CA2557841A1 Polony fluorescent in situ sequencing beads
09/09/2005CA2557508A1 Compositions and methods for the systemic treatment of arthritis
09/09/2005CA2557136A1 Flavivirus vaccines
09/09/2005CA2556632A1 Egf receptor epitope peptides and uses thereof
09/09/2005CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005CA2555245A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005CA2546853A1 Use of interfering rna in the production of transgenic animals
09/09/2005CA2497087A1 Novel genes encoding proteins involved in proanthocyanidin synthesis
09/08/2005US20050198711 Indeterminate gametophyte 1 (ig1), mutations of ig1, orthologs of ig1, and uses thereof
09/08/2005US20050198710 Method of improving soybean protein color by reducing levels of flavonol
09/08/2005US20050198699 Knockin non-human animal and tissue-specific MnSOD knockout non-human animal
09/08/2005US20050198695 Nematode ATP synthase subunit E-like sequences
09/08/2005US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs
09/08/2005US20050197316 Method of enhancing drainage of lacrimal system with purinergic receptor agonists
09/08/2005US20050197313 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
09/08/2005US20050197311 Vector comprising first polynucleotide encoding glucose responsive mRNA instability element, second polynucleotide encoding reporter polypeptide and promoter sequence; fluorescence based high throughput screening
09/08/2005US20050197310 TGaseII polypeptide antibodies; pulmonary, kidney, liver or ocular fibrosis; cardiac hypertrophy, atherosclerosis, restenosis; Alzheimer's and Parkinson's disease
09/08/2005US20050197309 Antisense modulation of dual specific phosphatase 5 expression
09/08/2005US20050197305 Methods and compositions for blocking progression of a disease state
09/08/2005US20050197298 Water soluble, prevention of neovascularization
09/08/2005US20050197293 Use of an IL-1 antagonist for treating arthritis
09/08/2005US20050196856 Polyelectrolyte-coated size-exclusion ion-exchange particles
09/08/2005US20050196853 Alpha-amylase variants
09/08/2005US20050196840 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic
09/08/2005US20050196836 Gamma-glutamylcysteine producing yeast